Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis

BACKGROUND AND OBJECTIVES: The kidney protective effects of renin-angiotensin system inhibitors are greater in people with higher levels of albuminuria at treatment initiation. Whether this applies to sodium-glucose cotransporter 2 (SGLT2) inhibitors is uncertain, particularly in patients with a ver...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin J Am Soc Nephrol
Autors principals: Jardine, Meg, Zhou, Zien, Lambers Heerspink, Hiddo J., Hockham, Carinna, Li, Qiang, Agarwal, Rajiv, Bakris, George L., Cannon, Christopher P., Charytan, David M., Greene, Tom, Levin, Adeera, Li, Jing-Wei, Neuen, Brendon L., Neal, Bruce, Oh, Richard, Oshima, Megumi, Pollock, Carol, Wheeler, David C., de Zeeuw, Dick, Zhang, Hong, Zinman, Bernard, Mahaffey, Kenneth W., Perkovic, Vlado
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011002/
https://ncbi.nlm.nih.gov/pubmed/33619120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.15260920
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars